HomeOpen Access NewsResearch & Innovation

Research & Innovation

Research and innovation: Europe’s quest for a global comeback

Jan Palmowski, Secretary-General of The Guild of European Research-Intensive Universities, examines the themes of research and innovation in Europe’s quest for a global comeback.

Nanomedicines: Depicting human health risks hindering clinical translation

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.

European Commission research budget labelled ‘most ambitious ever’

Carlos Moedas, the EU’s Research Commissioner proposed a €94.1 billion research budget to member states, pushing for increased spending on basic science and plans for a new innovation council to drive transformative ideas throughout Europe

Understanding the characterisation of sustainable materials

Moniek Tromp, Van t Hoff Institute for Molecular Sciences, Sustainable Materials Characterisation sheds light on sustainable materials and their benefits

How data processing from space can help save the earth

Michał Baćkowski, Managing Director, KP Labs part of FP Space shares his expert perspective on how data processing from space can help save the Earth 

Rediscovering observations of the environmental factors affecting tissue regeneration in aquatic species

Graciela A. Unguez, PhD, Professor of Biology and student Bahiyyih Mitchell at New Mexico State University explore the environmental factors affecting tissue regeneration in aquatic species

The challenge of commercialisation: Keeping an academic balance

Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry

Woody breast: A hard problem for the poultry industry

Dr Macdonald Wick, Associate Professor at The Ohio State University’s Department of Animal Sciences explains why Woody Breast is a hard problem for the poultry industry

Medical and pharmaceutical statistics research: Professional development courses

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University provides an overview of the professional development courses offered at the unit

Improving acute myeloid leukaemia (AML) outcomes

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved

Asthma: Understanding chronic inflammatory lung diseases

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective

UK seeks co-operation with Canada over trade opportunities in defence and security sectors

Leading technology companies in the UK showcased their products and services for land-based naval and aerospace use at CANSEC 2018 - Canada's largest defence industry event - in the hopes of securing industrial cooperation and joint ventures with Canadian companies

The amazing spiny mouse, the champion of mammalian regeneration

Malcolm Maden, Department of Biology & UF Genetics Institute, Gainesville, Florida, USA shares his expert opinion on the amazing spiny mouse, the champion of mammalian regeneration

Microbes and the rigour of space flight

William B. Miller, Jr., M.D. argues that without the planning to do so, we have launched microbial life from this planet

8 in 10 transport firms eligible for Research and Development tax relief

Recent findings from Catax, a specialist tax relief firm, has revealed that the majority of transport firms in the UK could claim for Research and Development (R&D) relief, but only a quarter are aware it even exists

EU Research Commissioner fights to protect a €100 billion investment

The EU’s research Commissioner, Carlos Moedas has demanded more commitment from member states on research and innovation spending, despite a widespread sense of reluctance throughout the European Union to increase the budget.

At the frontier of brain tumour research, we must leave no stone unturned

With the Government set to invest an additional £20 million into the research, diagnosis and development of treatments for brain tumours, Dr Ali Hansford elaborates on the need to talk more about how we are going to find the next blockbuster treatments for these devastating diseases

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders